Events

The Young Professionals Group of the Leukemia & Lymphoma Society’s (LLS) Rocky Mountain Chapter is excited for the 2nd Annual March Madness for a Cure event!  The bracket challenge will conclude with a Watch Party to be held at Lime Restaurant on the third floor of the Denver Pavilions on Monday April 6 at 5:30pm.  

This is a great opportunity to compete against family, friends and co-workers while supporting LLS and our fight against blood cancer. 

HERE'S HOW IT WORKS
With a minimum donation of $25, you will get to participate in our exclussive Bracket Challenge. Prizes will go to the Top 3 individuals with the best bracket. There are no limits to the amount of brackets purchased. 

In addition to participating in the bracket challenge, we hope you can join us at Lime Restaurant for the Watch partry on April 6. Tickets are only $10 more with the purchase of bracket. Watch party includes great food, 2 drink tickets, auction items and tons of prizes and giveaways while watching the final NCAA game.

To join the Bracket Challenge or Watch Party, please click on the appropriate tab on the left. DO NOT click on the 'Donate Now' button on the right to purchase anything. That button is for general donations only.

To register, sponsor, donate or find out more information go to http://www.lls.org/pages/rm/marchmadness 

ABOUT LLS

LLS has invested more than $1 billion in research to advance blood cancer therapies and save lives but we will not be satisfied until we find a cure. Last year alone, LLS invested approximately $70 million in cutting-edge research and our work is not done. Join us in the fight for a cure today—sign up for March Madness for a Cure!

LLS's continued advancements over the years, are responsible for the blood cancer survival rate doubling and tripling; in some cases, the survival rate has even quadrupled. And many LLS supported therapies not only help blood cancer patients but are now used to treat patients with rare forms of stomach and skin cancers. They're even being tested in clinical trials for patients with a range of cancers including lung, brain, breast, pancreatic and prostate cancers. LLS funded drugs like Gleevec, Sprycel, Arinza, Tasigna and Zolinza are now being tested for patients with other non-cancerous diseases like Diabetes, Rheumatoid Arthritis and Multiple Sclerosis.

We really are changing the face of blood cancer!